Literature DB >> 23907334

Genetic variants of peroxisome proliferator-activated receptor δ are associated with gastric cancer.

Christie Jeon1, Shen-Chih Chang, Lina Mu, Jinkou Zhao, Jian-Yu Rao, Qing-Yi Lu, Zuo-Feng Zhang.   

Abstract

BACKGROUND: Peroxisome proliferator-activated receptors (PPAR) are implicated in pathogenesis of insulin resistance and cancers of the digestive system. AIM: We investigated the associations of single nucleotide polymorphisms (SNPs) of PPAR δ and γ with gastric cancer and explored interactions with risk factors of gastric cancer.
METHODS: We conducted our analysis in a case-control study of 196 gastric cancer patients and 397 controls residing in the Taixing region of Jiangsu, China. Six SNPs in the PPARδ (rs2076167, rs3734254) and PPARγ genes (rs10865710, rs1801282, rs3856806, rs13306747) were genotyped. We employed logistic regression to evaluate the association between each genotype and gastric cancer and tested for gene-environment interaction with Helicobacter pylori (H. pylori) infection, smoking status, and meat and salt intake.
RESULTS: We found that the G/G variant rs2076167, in tight linkage disequilibrium with rs3734254 (R (2) = 0.97), was associated with increased risk of gastric cancer in a recessive model (OR 2.20, 95 % CI 1.12, 4.32). The association between G/G variant of rs2016167 and gastric cancer was particularly strong among those with higher salt intake (OR 5.11, 95 % CI 1.11, 23.5), but did not vary by H. pylori infection or smoking status.
CONCLUSION: We found that genetic variants of PPARδ were associated with gastric cancer. If the association is confirmed in larger studies, it may implicate a role for PPARδ activators, such as insulin-sensitizing agents, in prevention of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23907334      PMCID: PMC3783538          DOI: 10.1007/s10620-013-2770-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Processed meat consumption and stomach cancer risk: a meta-analysis.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2006-08-02       Impact factor: 13.506

2.  Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Authors:  Yaacov Barak; Debbie Liao; Weimin He; Estelita S Ong; Michael C Nelson; Jerrold M Olefsky; Richard Boland; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men's health study.

Authors:  Raquel Villegas; Gong Yang; DaKe Liu; Yong-Bing Xiang; Hui Cai; Wei Zheng; Xiao Ou Shu
Journal:  Br J Nutr       Date:  2007-05       Impact factor: 3.718

4.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

5.  Global estimates of cancer prevalence for 27 sites in the adult population in 2008.

Authors:  Freddie Bray; Jian-Song Ren; Eric Masuyer; Jacques Ferlay
Journal:  Int J Cancer       Date:  2012-07-26       Impact factor: 7.396

6.  PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.

Authors:  Karen R Reed; Owen J Sansom; Anthony J Hayes; Andreas J Gescher; Douglas J Winton; Jeffrey M Peters; Alan R Clarke
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

7.  Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study.

Authors:  X O Shu; G Yang; F Jin; D Liu; L Kushi; W Wen; Y-T Gao; W Zheng
Journal:  Eur J Clin Nutr       Date:  2004-01       Impact factor: 4.016

Review 8.  Targeting vacuolar H+-ATPases as a new strategy against cancer.

Authors:  Stefano Fais; Angelo De Milito; Haiyan You; Wenxin Qin
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.

Authors:  Rajnish A Gupta; Dingzhi Wang; Sharada Katkuri; Haibin Wang; Sudhansu K Dey; Raymond N DuBois
Journal:  Nat Med       Date:  2004-02-01       Impact factor: 53.440

10.  Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

Authors:  Fred S Harman; Christopher J Nicol; Holly E Marin; Jerrold M Ward; Frank J Gonzalez; Jeffrey M Peters
Journal:  Nat Med       Date:  2004-03-28       Impact factor: 53.440

View more
  4 in total

Review 1.  Role of Helicobacter pylori infection in pathogenesis of gastric carcinoma.

Authors:  Rong-Guang Zhang; Guang-Cai Duan; Qing-Tang Fan; Shuai-Yin Chen
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

Authors:  Xiangsheng Zuo; Yasunori Deguchi; Weiguo Xu; Yi Liu; Haiyan S Li; Daoyan Wei; Rui Tian; Weidong Chen; Min Xu; Yaying Yang; Shen Gao; Jonathan C Jaoude; Fuyao Liu; Sarah P Chrieki; Micheline J Moussalli; Mihai Gagea; Manu M Sebastian; Xiaofeng Zheng; Dongfeng Tan; Russell Broaddus; Jing Wang; Nadim J Ajami; Alton G Swennes; Stephanie S Watowich; Imad Shureiqi
Journal:  Gastroenterology       Date:  2019-03-15       Impact factor: 22.682

3.  PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Inflamm Cell Signal       Date:  2014-10-19

4.  PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis.

Authors:  Hao Ding; Yuanmei Chen; Hao Qiu; Chao Liu; Yafeng Wang; Mingqiang Kang; Weifeng Tang
Journal:  Oncotarget       Date:  2017-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.